Kaplan–Meier survival analysis demonstrated significantly reduced overall survival (OS) in ccRCC patients with high PIEZO1 expression, both at the protein and mRNA levels. The gene discussed is PIEZO1; the disease is nonpapillary renal cell carcinoma.